Skip to main content
Erschienen in: Clinical Rheumatology 8/2020

14.03.2020 | Review Article

MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies

verfasst von: Zahra Bagheri-Hosseinabadi, Danyal Imani, Hassan Yousefi, Mitra Abbasifard

Erschienen in: Clinical Rheumatology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Rheumatoid arthritis (RA) is the most common autoimmune rheumatic disease, in which an epigenetic implication in the disease etiopathogenesis has been noted. Here in this meta-analysis, we attempted to investigate the pooled association of methylenetetrahydrofolate reductase (MTHFR) gene C677T and A1298C polymorphisms and susceptibility to RA risk. A systematic search was performed in the main databases, including MEDLINE and Scopus to search for studies assessing the association between MTHFR gene C677T and A1298C polymorphisms and the risk of RA prior to December 2019. In this meta-analysis, 15 studies with 2165 patients and 1751 healthy controls for C677T SNP and 14 studies containing 2021 patients and 1760 healthy controls for A1298C SNP were included. A significant positive association between C677T SNP and RA risk was recognized in the dominant, recessive, and allelic model, but not TT and CT genotypes. The results indicated that the risk of RA in African population was increased under all genotype models while these results were repeated in Asian population just for recessive model, allelic model, and TT genotype. Moreover, the analysis of A1298C SNP demonstrated a significant association in overall population according to only the recessive model and CC genotype. Subgroup analysis according to the genotyping method indicated that RFLP-PCR method could impress the results of association between MTHFR gene A1298C and C677T SNPs and RA risk. The outcome of this meta-analysis indicated that MTHFR gene C677T SNP was much possibly be associated with RA risk.
Literatur
1.
Zurück zum Zitat Chua JR, Jamal S, Riad M, Castrejon I, Malfait AM, Block JA, Pincus T (2019) Disease burden in osteoarthritis (OA) is similar to rheumatoid arthritis (RA) at initial rheumatology visit and significantly greater 6-months later. Arthritis Rheumatol 71(8):1276–1284 Chua JR, Jamal S, Riad M, Castrejon I, Malfait AM, Block JA, Pincus T (2019) Disease burden in osteoarthritis (OA) is similar to rheumatoid arthritis (RA) at initial rheumatology visit and significantly greater 6-months later. Arthritis Rheumatol 71(8):1276–1284
2.
Zurück zum Zitat Conigliaro P, Triggianese P, De Martino E, Chimenti MS, Sunzini F, Viola A, Canofari C, Perricone R (2019) Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev 18(7):706–713 Conigliaro P, Triggianese P, De Martino E, Chimenti MS, Sunzini F, Viola A, Canofari C, Perricone R (2019) Challenges in the treatment of rheumatoid arthritis. Autoimmun Rev 18(7):706–713
3.
Zurück zum Zitat Tobón GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9(5):A288–A292PubMedCrossRef Tobón GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9(5):A288–A292PubMedCrossRef
5.
Zurück zum Zitat Orozco G, Barton A (2010) Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol 6(1):61–75PubMedCrossRef Orozco G, Barton A (2010) Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol 6(1):61–75PubMedCrossRef
7.
Zurück zum Zitat Razi B, Reykandeh SE, Alizadeh S, Amirzargar A, Saghazadeh A, Rezaei N (2019) TIM family gene polymorphism and susceptibility to rheumatoid arthritis: systematic review and meta-analysis. PLoS One 14(2):e0211146PubMedPubMedCentralCrossRef Razi B, Reykandeh SE, Alizadeh S, Amirzargar A, Saghazadeh A, Rezaei N (2019) TIM family gene polymorphism and susceptibility to rheumatoid arthritis: systematic review and meta-analysis. PLoS One 14(2):e0211146PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR (2008) Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci 105(49):19396–19401PubMedCrossRefPubMedCentral Flores-Borja F, Jury EC, Mauri C, Ehrenstein MR (2008) Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis. Proc Natl Acad Sci 105(49):19396–19401PubMedCrossRefPubMedCentral
9.
Zurück zum Zitat Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, Liew A, Khalili H, Chandrasekaran A, Davies LR (2007) TRAF1–C5 as a risk locus for rheumatoid arthritis—a genomewide study. N Engl J Med 357(12):1199–1209PubMedPubMedCentralCrossRef Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, Liew A, Khalili H, Chandrasekaran A, Davies LR (2007) TRAF1–C5 as a risk locus for rheumatoid arthritis—a genomewide study. N Engl J Med 357(12):1199–1209PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75(2):330–337PubMedPubMedCentralCrossRef Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM (2004) A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75(2):330–337PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Takizawa Y, Sawada T, Suzuki A, Yamada R, Inoue T, Yamamoto K (2005) Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol 34(3):212–215PubMedCrossRef Takizawa Y, Sawada T, Suzuki A, Yamada R, Inoue T, Yamamoto K (2005) Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol 34(3):212–215PubMedCrossRef
12.
Zurück zum Zitat Matmati M, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M, Geboes L, Louagie E, Mc Guire C, Vereecke L (2011) A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43(9):908–912PubMedCrossRef Matmati M, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M, Geboes L, Louagie E, Mc Guire C, Vereecke L (2011) A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43(9):908–912PubMedCrossRef
13.
Zurück zum Zitat Owen S, Lunt M, Bowes J, Hider S, Bruce I, Thomson W, Barton A (2013) MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Pharmacogenomics J 13(2):137–147PubMedCrossRef Owen S, Lunt M, Bowes J, Hider S, Bruce I, Thomson W, Barton A (2013) MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms. Pharmacogenomics J 13(2):137–147PubMedCrossRef
14.
Zurück zum Zitat Moores CJ, Fenech M, O’Callaghan NJ (2011) Telomere dynamics: the influence of folate and DNA methylation. Ann N Y Acad Sci 1229(1):76–88PubMedCrossRef Moores CJ, Fenech M, O’Callaghan NJ (2011) Telomere dynamics: the influence of folate and DNA methylation. Ann N Y Acad Sci 1229(1):76–88PubMedCrossRef
15.
Zurück zum Zitat Pietrzik K, Bailey L, Shane B (2010) Folic acid and L-5-methyltetrahydrofolate. Clin Pharmacokinet 49(8):535–548PubMedCrossRef Pietrzik K, Bailey L, Shane B (2010) Folic acid and L-5-methyltetrahydrofolate. Clin Pharmacokinet 49(8):535–548PubMedCrossRef
16.
Zurück zum Zitat Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K (2009) Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C> T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers 14(1):49–54PubMedCrossRef Fujimaki C, Hayashi H, Tsuboi S, Matsuyama T, Kosuge K, Yamada H, Inoue K, Itoh K (2009) Plasma total homocysteine level and methylenetetrahydrofolate reductase 677C> T genetic polymorphism in Japanese patients with rheumatoid arthritis. Biomarkers 14(1):49–54PubMedCrossRef
17.
Zurück zum Zitat Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA (2010) A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 12(2):R71PubMedPubMedCentralCrossRef Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA (2010) A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 12(2):R71PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9(8):652–656PubMedCrossRef Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R (1998) Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mamm Genome 9(8):652–656PubMedCrossRef
19.
Zurück zum Zitat Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, Kotsis A (2005) The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 222(1):57–65PubMedCrossRef Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, Kotsis A (2005) The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 222(1):57–65PubMedCrossRef
20.
Zurück zum Zitat van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5):1044–1051PubMedPubMedCentralCrossRef van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62(5):1044–1051PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269PubMedCrossRef Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269PubMedCrossRef
22.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed
23.
Zurück zum Zitat Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193–206PubMedCrossRef Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193–206PubMedCrossRef
24.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed
25.
Zurück zum Zitat Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed
26.
Zurück zum Zitat Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics:1088–1101 Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics:1088–1101
28.
Zurück zum Zitat Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Atta IA, Mevorach D, Friedman G, Ben-Yehuda A (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63(10):1227–1231PubMedPubMedCentralCrossRef Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Atta IA, Mevorach D, Friedman G, Ben-Yehuda A (2004) Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis 63(10):1227–1231PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Hughes LB, Beasley TM, Patel H, Tiwari HK, Morgan SL, Baggott JE, Saag KG, McNicholl J, Moreland LW, Alarcón GS (2006) Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 65(9):1213–1218PubMedPubMedCentralCrossRef Hughes LB, Beasley TM, Patel H, Tiwari HK, Morgan SL, Baggott JE, Saag KG, McNicholl J, Moreland LW, Alarcón GS (2006) Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis. Ann Rheum Dis 65(9):1213–1218PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Rubini M, Padovan M, Baricordi O, Fotinidi M, Govoni M, Trotta F (2008) The c. 1298A> C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients. Clin Exp Rheumatol 26(1):163 Rubini M, Padovan M, Baricordi O, Fotinidi M, Govoni M, Trotta F (2008) The c. 1298A> C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients. Clin Exp Rheumatol 26(1):163
31.
Zurück zum Zitat Cai YMG (2009) Linkage study on methylenetetrahydrofolate reductase single nucleotide polymorphisms and methotrexate-related adverse effects in patients with rheumatoid arthritis. Chin J Prim Med Pharm 1155-1157:16 Cai YMG (2009) Linkage study on methylenetetrahydrofolate reductase single nucleotide polymorphisms and methotrexate-related adverse effects in patients with rheumatoid arthritis. Chin J Prim Med Pharm 1155-1157:16
32.
Zurück zum Zitat Taşbaş Ö, Borman P, Karabulut HG, Tükün A, Yorgancıoğlu R (2011) The frequency of A1298C and C677T polymorphisms of the methylentetrahydrofolate gene in Turkish patients with rheumatoid arthritis: relationship with methotrexate toxicity. Open Rheumatol J 5:30PubMedPubMedCentralCrossRef Taşbaş Ö, Borman P, Karabulut HG, Tükün A, Yorgancıoğlu R (2011) The frequency of A1298C and C677T polymorphisms of the methylentetrahydrofolate gene in Turkish patients with rheumatoid arthritis: relationship with methotrexate toxicity. Open Rheumatol J 5:30PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Plaza-Plaza JC, Aguilera M, Canadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA (2012) Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Omics: a journal of integrative biology 16(11):589–595PubMedCrossRef Plaza-Plaza JC, Aguilera M, Canadas-Garre M, Chemello C, González-Utrilla A, Faus Dader MJ, Calleja MA (2012) Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Omics: a journal of integrative biology 16(11):589–595PubMedCrossRef
34.
Zurück zum Zitat Inanir A, Yigit S, Tekcan A, Tural S, Kismali G (2013) IL-4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects. Immunol Lett 152(2):104–108PubMedCrossRef Inanir A, Yigit S, Tekcan A, Tural S, Kismali G (2013) IL-4 and MTHFR gene polymorphism in rheumatoid arthritis and their effects. Immunol Lett 152(2):104–108PubMedCrossRef
35.
Zurück zum Zitat Boughrara W, Aberkane M, Fodil M, Benzaoui A, Dorgham S, Zemani F, Dahmani C, Petit Teixeira E, Boudjema A (2015) Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: a case-control study.Acta Reumatol Port 40(4):363–71 Boughrara W, Aberkane M, Fodil M, Benzaoui A, Dorgham S, Zemani F, Dahmani C, Petit Teixeira E, Boudjema A (2015) Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: a case-control study.Acta Reumatol Port 40(4):363–71
36.
Zurück zum Zitat Saad MN, Mabrouk MS, Eldeib AM, Shaker OG (2015) Genetic case-control study for eight polymorphisms associated with rheumatoid arthritis. PLoS One 10(7):e0131960PubMedPubMedCentralCrossRef Saad MN, Mabrouk MS, Eldeib AM, Shaker OG (2015) Genetic case-control study for eight polymorphisms associated with rheumatoid arthritis. PLoS One 10(7):e0131960PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Saleh MM, Irshaid YM, Mustafa KN (2015) Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients. Int J Clin Pharmacol Ther 53(2):154–162PubMedCrossRef Saleh MM, Irshaid YM, Mustafa KN (2015) Methylene tetrahydrofolate reductase genotypes frequencies: association with toxicity and response to methotrexate in rheumatoid arthritis patients. Int J Clin Pharmacol Ther 53(2):154–162PubMedCrossRef
38.
Zurück zum Zitat Hashiguchi M, Shimizu M, Hakamata J, Tsuru T, Tanaka T, Suzaki M, Miyawaki K, Chiyoda T, Takeuchi O, Hiratsuka J (2016) Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. J Pharm Health Care Sci 2(1):35PubMedPubMedCentralCrossRef Hashiguchi M, Shimizu M, Hakamata J, Tsuru T, Tanaka T, Suzaki M, Miyawaki K, Chiyoda T, Takeuchi O, Hiratsuka J (2016) Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. J Pharm Health Care Sci 2(1):35PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Shaker OG, El-Demellawy HH, Salem MN, Eesa NN (2016) Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in rheumatoid arthritis patients: correlation with serum osteopontin levels and disease activity. The Egyptian Rheumatologist 38(4):283–288CrossRef Shaker OG, El-Demellawy HH, Salem MN, Eesa NN (2016) Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in rheumatoid arthritis patients: correlation with serum osteopontin levels and disease activity. The Egyptian Rheumatologist 38(4):283–288CrossRef
40.
Zurück zum Zitat González-Mercado MG, Rivas F, Gallegos-Arreola MP, Morán-Moguel MC, Salazar-Páramo M, González-López L, Gámez-Nava JI, Munoz-Valle JF, Medina-Coss y Leon R, González-Mercado A (2017) MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C polymorphisms and disease activity in mexicans with rheumatoid arthritis treated with methotrexate. Genet Test Mol Biomarkers 21(11):698–704PubMedPubMedCentralCrossRef González-Mercado MG, Rivas F, Gallegos-Arreola MP, Morán-Moguel MC, Salazar-Páramo M, González-López L, Gámez-Nava JI, Munoz-Valle JF, Medina-Coss y Leon R, González-Mercado A (2017) MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C polymorphisms and disease activity in mexicans with rheumatoid arthritis treated with methotrexate. Genet Test Mol Biomarkers 21(11):698–704PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat El-Aziz TAA, Mohamed RH (2017) Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis. Gene 610:127–132CrossRef El-Aziz TAA, Mohamed RH (2017) Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis. Gene 610:127–132CrossRef
42.
Zurück zum Zitat Premkumar B, Sivaraman J, Nandini R (2018) Methylenetetrahydrofolate reductase gene polymorphism MTHFR A1298C and rheumatoid arthritis in south indian population. Drug Invention Today 10(3) Premkumar B, Sivaraman J, Nandini R (2018) Methylenetetrahydrofolate reductase gene polymorphism MTHFR A1298C and rheumatoid arthritis in south indian population. Drug Invention Today 10(3)
43.
Zurück zum Zitat Wang S, Zuo S, Liu Z, Ji X, Yao Z, Wang X (2019) Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis. J Int Med Res 1–11 Wang S, Zuo S, Liu Z, Ji X, Yao Z, Wang X (2019) Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis. J Int Med Res 1–11
44.
Zurück zum Zitat Lazzerini P, Selvi E, Lorenzini S, Capecchi P, Ghittoni R, Bisogno S, Catenaccio M, Marcolongo R, Galeazzi M, Laghi-Pasini F (2006) Homocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 24(4):387–393PubMed Lazzerini P, Selvi E, Lorenzini S, Capecchi P, Ghittoni R, Bisogno S, Catenaccio M, Marcolongo R, Galeazzi M, Laghi-Pasini F (2006) Homocysteine enhances cytokine production in cultured synoviocytes from rheumatoid arthritis patients. Clin Exp Rheumatol 24(4):387–393PubMed
45.
Zurück zum Zitat MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46(3):632–639PubMedCrossRef MacKay K, Eyre S, Myerscough A, Milicic A, Barton A, Laval S, Barrett J, Lee D, White S, John S (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46(3):632–639PubMedCrossRef
46.
Zurück zum Zitat Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24(1):56–59PubMed Rosenblatt DS (2001) Methylenetetrahydrofolate reductase. Clin Invest Med 24(1):56–59PubMed
47.
Zurück zum Zitat Favalli EG, Biggioggero M, Meroni PL (2014) Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an “anchor” drug? Autoimmun Rev 13(11):1102–1108PubMedCrossRef Favalli EG, Biggioggero M, Meroni PL (2014) Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an “anchor” drug? Autoimmun Rev 13(11):1102–1108PubMedCrossRef
48.
Zurück zum Zitat Haagsma CJ, Blom HJ, van Riel PL, van’t Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, van de Putte LB (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58(2):79–84PubMedPubMedCentralCrossRef Haagsma CJ, Blom HJ, van Riel PL, van’t Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, van de Putte LB (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58(2):79–84PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat James HM, Gillis D, Hissaria P, Lester S, Somogyi AA, Cleland LG, Proudman SM (2008) Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis. J Rheumatol 35(4):562–571PubMed James HM, Gillis D, Hissaria P, Lester S, Somogyi AA, Cleland LG, Proudman SM (2008) Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis. J Rheumatol 35(4):562–571PubMed
50.
Zurück zum Zitat Fisher MC, Cronstein BN (2009) Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J Rheumatol 36(3):539–545PubMedPubMedCentralCrossRef Fisher MC, Cronstein BN (2009) Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. J Rheumatol 36(3):539–545PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129(9):1656–1661PubMedCrossRef Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H (1999) A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129(9):1656–1661PubMedCrossRef
52.
Zurück zum Zitat Razi B, Imani D, Makoui MH, Rezaei R, Aslani S (2020) Association between MTHFR gene polymorphism and susceptibility to autism spectrum disorders: systematic review and meta-analysis. Res Autism Spectr Disord 70:101473CrossRef Razi B, Imani D, Makoui MH, Rezaei R, Aslani S (2020) Association between MTHFR gene polymorphism and susceptibility to autism spectrum disorders: systematic review and meta-analysis. Res Autism Spectr Disord 70:101473CrossRef
53.
Zurück zum Zitat Song GG, Bae S-C, Lee YH (2014) Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin Rheumatol 33(12):1715–1724PubMedCrossRef Song GG, Bae S-C, Lee YH (2014) Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin Rheumatol 33(12):1715–1724PubMedCrossRef
54.
Zurück zum Zitat Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64(3):169–172PubMedCrossRef Weisberg I, Tran P, Christensen B, Sibani S, Rozen R (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64(3):169–172PubMedCrossRef
56.
Zurück zum Zitat Lopez-Olivo M, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano A, Cota-Sanchez A, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz E, Gamez-Nava J (2006) Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112–116PubMedCrossRef Lopez-Olivo M, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano A, Cota-Sanchez A, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz E, Gamez-Nava J (2006) Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112–116PubMedCrossRef
57.
Zurück zum Zitat Cornélis F, Fauré S, Martinez M, Prud’homme J-F, Fritz P, Dib C, Alves H, Barrera P, De Vries N, Balsa A (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci 95(18):10746–10750PubMedCrossRefPubMedCentral Cornélis F, Fauré S, Martinez M, Prud’homme J-F, Fritz P, Dib C, Alves H, Barrera P, De Vries N, Balsa A (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci 95(18):10746–10750PubMedCrossRefPubMedCentral
58.
Zurück zum Zitat Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10(12):1891–1895PubMedCrossRef Shiozawa S, Hayashi S, Tsukamoto Y, Goko H, Kawasaki H, Wada T, Shimizu K, Yasuda N, Kamatani N, Takasugi K (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10(12):1891–1895PubMedCrossRef
59.
Zurück zum Zitat Cen H, Huang H, Zhang L-N, Liu L-Y, Zhou L, Xin X-F, Zhuo R-J (2017) Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis. Clin Rheumatol 36(2):287–297PubMedCrossRef Cen H, Huang H, Zhang L-N, Liu L-Y, Zhou L, Xin X-F, Zhuo R-J (2017) Associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with genetic susceptibility to rheumatoid arthritis: a meta-analysis. Clin Rheumatol 36(2):287–297PubMedCrossRef
Metadaten
Titel
MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies
verfasst von
Zahra Bagheri-Hosseinabadi
Danyal Imani
Hassan Yousefi
Mitra Abbasifard
Publikationsdatum
14.03.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 8/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05031-5

Weitere Artikel der Ausgabe 8/2020

Clinical Rheumatology 8/2020 Zur Ausgabe

Clinical Image

Spotted bone disease

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.